Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Dementia (London, England)|May 1, 2015
Junior doctor dementia champions in a district general hospital (innovative practice)Iain Wilkinson, Anna Coates, Sophie Merrick, et al.Qualitative Health Research|November 16, 2024
Fraudulent Participation in Online Qualitative Studies: Practical Recommendations on an Emerging PhenomenonKhaylen Mistry, Sophie Merrick, Melissa Cabecinha, et al.British Journal of Cancer|June 17, 2024
Hit it hard: qualitative patient perspectives on the optimisation of immune checkpoint inhibitionSophie Merrick, Hannah L Rush, Susanna Daniels, et al.Prostate Cancer|July 14, 2012
Dose-escalated hypofractionated intensity-modulated radiotherapy in high-risk carcinoma of the prostate: outcome and late toxicityDavid Thomson, Sophie Merrick, Ric Swindell, et al.The Lancet. Oncology|May 3, 2025
Determining the optimal use of approved drugs in oncologyGauthier Bouche, Duncan Gilbert, Matteo Quartagno, et al.Journal for Immunotherapy of Cancer|October 9, 2020
Impact of age on the toxicity of immune checkpoint inhibitionAmit Samani, Shuai Zhang, Laura Spiers, et al.BJU International|July 31, 2025
Preferences between three options for androgen deprivation therapy: a focus group studyHannah L Rush, Sophie Merrick, John Marshall, et al.Contemporary Clinical Trials|December 15, 2022
REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): A multi-arm phase II basket trial testing reduced intensity immunotherapy across different cancersSophie Merrick, Matthew Nankivell, Matteo Quartagno, et al.British Journal of Cancer|April 24, 2024
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United KingdomDaire Hanna, Sophie Merrick, Aruni Ghose, et al.Pageof 1